Berkshire Asset Management LLC/Pa / ABT
Berkshire Asset Management LLC/Pa’s Abbott Laboratories Position
Does Berkshire Asset Management LLC/Pa own Abbott Laboratories (ABT)? Yes — 306.7K shares worth $31M (+1.35% of its 13F portfolio) as of Q1 2026, up from 301.1K shares the prior filed quarter.
Position Value
$31M
Q1 2026
Shares
306.7K
% of Portfolio
+1.35%
Quarters Held
29
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 306.7K | $31M | +1.35% |
| Q4 2025 | 301.1K | $38M | +1.66% |
| Q3 2025 | 305.4K | $41M | +1.74% |
| Q2 2025 | 307.3K | $42M | +1.90% |
| Q1 2025 | 308.4K | $41M | +1.98% |
| Q4 2024 | 304.6K | $38M | +1.80% |
| Q3 2024 | 306.1K | $32M | +1.62% |
| Q2 2024 | 306.1K | $32M | +1.59% |
| Q1 2024 | 288.7K | $33M | +1.74% |
| Q4 2023 | 287.9K | $32M | +1.81% |
| Q3 2023 | 288.9K | $28M | +1.74% |
| Q2 2023 | 290.9K | $32M | +1.88% |
| Q4 2022 | 286.9K | $31M | +2.02% |
| Q3 2022 | 278.0K | $27M | +1.90% |
| Q2 2022 | 280.0K | $30M | +1.99% |
| Q1 2022 | 273.5K | $32M | +2.04% |
| Q4 2021 | 269.2K | $38M | +2.31% |
| Q3 2021 | 272.5K | $32M | +2.15% |
| Q2 2021 | 271.2K | $31M | +2.12% |
| Q1 2021 | 259.4K | $31M | +2.31% |
| Q4 2020 | 277.3K | $30M | +2.34% |
| Q3 2020 | 260.3K | $28M | +2.73% |
| Q2 2020 | 283.9K | $26M | +2.39% |
| Q1 2020 | 276.2K | $22M | +2.27% |
| Q4 2019 | 276.4K | $24M | +2.04% |
| Q3 2019 | 287.1K | $24M | +2.07% |
| Q2 2019 | 283.1K | $24M | +1.97% |
| Q1 2019 | 285.4K | $23M | +1.94% |
| Q4 2018 | 287.0K | $21M | +1.94% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Berkshire Asset Management LLC/Pa’s full portfolio or all institutional holders of ABT.